R1 RCM Inc

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

R1 RCM Inc (RCM) posts strong Q4 results, eyes Cloudmed growth

R1 RCM Inc (RCM) delivered robust financial performance in Q4 2022, focusing on operational excellence, technology investments, and customer engagement. Challenges include integration efforts and seasonality affecting incentive fees. The company is poised for growth with opportunities in Cloudmed expansion and AI utilization.

R1 RCM Inc (RCM) reports strong Q1 results and growth opportunities

R1 RCM Inc (RCM) delivered strong Q1 results, with a focus on operational improvements, robust Cloudmed growth, and positive financial outlook for 2023.
The company showcased resilience in stable patient self-pay trends, improving payer reimbursement timelines, and strategic capacity for onboarding new NPR, positioning itself for continued success.
Challenges include industry financial pressures, sustaining growth in legacy business, and managing operational costs effectively, requiring strategic adaptation and continuous innovation.
Opportunities lie in pipeline visibility for deals, sequential EBITDA growth, integration of Cloudmed capabilities, and strategic onboarding plans, offering avenues for expansion and profitability.

R1 RCM Inc reports robust Q2 earnings, eyes growth opportunities

R1 RCM Inc's Q2 performance was strong, with a focus on technology and operational enhancements. Challenges include revenue adjustments and workforce implications of automation. Opportunities lie in improved payer dynamics and growth through physician market focus and cross-selling.

R1 RCM Inc reports robust Q3 performance and eyes growth

R1 RCM Inc's Q3 earnings call highlighted strong financial performance, strategic priorities, and challenges in pediatric contracts and integration issues.
The company's focus on revenue optimization, leveraging technology, and partnership with Microsoft positions it well for growth opportunities within the customer base and offshoring initiatives.
While facing challenges in deal timings and debt repayment, R1 RCM Inc's emphasis on operational metrics, customer relationships, and workforce management presents avenues for continued success and industry leadership.

R1 RCM Inc reports robust Q4 earnings, eyes growth opportunities

R1 RCM Inc's Q4 2023 earnings call highlighted strong financial performance, strategic objectives for 2023, and a confident outlook for sustainable growth and shareholder value creation.
The company's emphasis on customer-centricity, AI integration, and operational efficiency underscores its strengths in revenue growth and market positioning.
While facing challenges in credit allowances and customer health, R1 RCM Inc aims to leverage opportunities in reduced costs, synergies from acquisitions, and strategic sales to drive future growth.

R1 RCM reports resilient Q1 performance post-cyberattack, eyes growth

R1 RCM showcased resilience in Q1 2024 despite the Change Healthcare cyberattack, focusing on growth strategies, operational excellence, and technology innovation.
The company faces challenges from the cyberattack impact on KPIs and vendor changes but sees opportunities in the managed care environment and customer engagement.
Overall, R1 RCM remains optimistic about transforming the industry through technology and expertise, with a strong market demand for its solutions.

R1 RCM Inc reports robust Q2 earnings amidst cyberattack challenges

R1 RCM Inc's Q2 2024 earnings call showcased strong financial performance, operational resilience in the face of cyberattacks, and a strategic focus on growth initiatives. The company faces challenges related to pending transactions and cyberattack impacts but sees opportunities in expanding its platform and leveraging technology for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Although the revenue and EPS for R1 RCM INC (RCM) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About R1 RCM INC (RCM) Q3 Earnings

R1 RCM Inc. (RCM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to break-even earnings per share a year ago.

R1 RCM Inc. (RCM) Reports Q3 Loss, Tops Revenue Estimates

Cepton

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cepton, Inc. (NASDAQ:CPTN)'s sale to KOITO MANUFACTURING CO., LTD. for $3.17 per share in cash.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CPTN and RCM on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into R1 Rcm Inc.

NEW YORK, NY / ACCESSWIRE / October 30, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into R1 Rcm Inc

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into R1 Rcm Inc

/ ACCESSWIRE / October 23, 2024 / NEW YORK, NY / ACCESSWIRE / October 23, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into R1 Rcm Inc

NEW YORK, NY / ACCESSWIRE / October 22, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into R1 RCM Inc

NEW YORK, NY / ACCESSWIRE / October 16, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into R1 Rcm Inc

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into R1 Rcm Inc.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of R1 RCM Inc. (NASDAQ: RCM) to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 per share is fair to R1 shareholders. Halper Sadeh encourages R1 shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

RCM Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of R1 RCM Inc. is Fair to Shareholders

PHILADELPHIA, PA / ACCESSWIRE / August 19, 2024 / Kehoe Law Firm, P.C. is investigating whether the sale of R1 RCM Inc. (NASDAQ:RCM) is fair to R1 RCM shareholders and whether the Board of Directors of R1 RCM breached its fiduciary duties in connection with the proposed acquisition of the company by investment funds affiliated with TowerBrook Capital Partners L.P.

R1 RCM Stock - Investigation Regarding the Fairness and Adequacy of the Sale of R1 RCM Inc. - Contact Kehoe Law Firm, P.C. For Details - RCM

Enstar Group

NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, ESGR on Behalf of Shareholders

R1 RCM Inc. (NASDAQ:RCM ) Q2 2024 Results Conference Call August 7, 2024 8:00 AM ET Company Participants Evan Smith - Senior Vice President, Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Operator Thank you for standing by. My name is Eric, and I will be your conference operator today.

R1 RCM Inc. (RCM) Q2 2024 Earnings Call Transcript

The headline numbers for R1 RCM INC (RCM) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

R1 RCM INC (RCM) Reports Q2 Earnings: What Key Metrics Have to Say

R1 RCM Inc. (RCM) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago.

R1 RCM Inc. (RCM) Reports Q2 Loss, Lags Revenue Estimates

NEW YORK , Aug. 2, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating R1 RCM Inc. (Nasdaq: RCM ), relating to its proposed sale to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice.

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of R1 RCM Inc. - RCM

NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating R1 RCM Inc . ( Nasdaq : RCM ) , relating to its proposed sale to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice. Under the terms of the agreement, RCM stock will be automatically converted into the right to receive $14.30 per share.

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of R1 RCM Inc. – RCM

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of R1 RCM Inc. (NasdaqGS: RCM) to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice. Under the terms of the proposed transaction, shareholders of R1 will receive $14.30 in cash for each share of R1 that they own. KSF is seeking to determine whether this consideration an.

R1 RCM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of R1 RCM Inc. - RCM

MONSEY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM, Inc. (Nasdaq: RCM) (“RCM”) for $14.30 per share in cash to TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CDR”).

RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice

MILWAUKEE, Aug. 1, 2024 /PRNewswire/ -- Ademi LLP is investigating R1 (NASDAQ: RCM) for possible breaches of fiduciary duty and other violations of law in its transaction with TowerBrook and CD&R. Click here to learn how to join our investigation https://www.ademilaw.com/case/r1rcm-inc or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether R1 RCM Inc. has obtained a Fair Price for its Public Shareholders

RCM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of R1 RCM Inc. Is Fair to Shareholders

R1 RCM Inc's stock RCM was up 2.8% in premarket trading on Thursday after the Murray, Utah-based revenue cycle management company for hospitals agreed to be taken private by TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 a share. The deal values the company at about $8.9 billion.

R1 RCM to be taken over for $8.9 billion

MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition by New Mountain Capital for $13.25 per share. If you invested in R1 RCM, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/r1-rcm-inc.

RCM STOCK ALERT: R1 RCM Inc. Shareholders are Notified that BFA Law is Investigating the Potential Acquisition of the Company – Contact BFA Law for Information

News for R1 RCM Inc Stock (RCM)